COFFMAN ROBERT 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Jun 4, 2018
Insider Transaction Report
Form 4
COFFMAN ROBERT
Chief Scientific Officer & VP
Transactions
- Exercise/Conversion
Common Stock
2018-06-02+54,703→ 105,288 total - Exercise/Conversion
Restricted Stock unit
2018-06-02−54,703→ 54,702 totalExp: 2024-06-01→ Common Stock (54,703 underlying)
Footnotes (1)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over two years with 50% vesting on each annual anniversary of June 2, 2017.